NL-OMON34382已完成不适用
A single-center, single-blind study to investigate skin response to sub-therapeutic doses of taspoglutide in GLP-1 analogue naive healthy volunteers - Skin response to subtherapeutic doses of taspoglutide
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male or female
- •Age : 18-65 yrs, inclusive
- •BMI : 20.0-35.0 kg/m2, inclusive
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 90 days from the start of the study. In case of having participated in more than 3 other drug studies (for men) / more than 2 other drug studies (for women) in the 10 months prior to the start of this study, or when having donated more than 1.5 liters of blood (for men) / more than 1.0 liters of blood (for women) in the 10 months prior to the start of this study
研究者
相似试验
招募中
2 期
To assess the efficacy of investigational product for its moisturization on healthy human female subjectsCTRI/2013/07/003803Hindustan Unilever Limited40
尚未招募
不适用
A prospective, single-centre study to investigate the role of Optical Coherence Tomography and fractional flow reserve for post coronary angioplasty stent optimisatioCTRI/2021/04/032543PGIMER
尚未招募
Unknown
A prospective, Single-Centre study to investigate the plaque characteristics of lesions in young Indian patients of =40 yearsCTRI/2024/01/061165Dr Nityanand Tripathi
进行中（未招募）
不适用
A single-center, randomized, single-blind study in parallel groups to evaluate the efficacy and safety of a new intravenous iron HES preparation as compared to intravenous iron dextran (Cosmofer) in anemic patientsAnemia in chronic kidney diseaseEUCTR2009-014351-72-ATSerumwerk Bernburg
进行中（未招募）
1 期
A single-center, randomized, single-blind study in parallel groups to evaluate the efficacy and safety of a new intravenous iron HES preparation as compared to intravenous iron dextran (Cosmofer®) in EPO (erythropoietin) naïve patients suffering from anemiaEUCTR2009-014351-72-SKSerumwerk Bernburg50